Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and Ketamine for Chronic Pain
NCT03249025Unknown
- Sponsor
- Hamilton Health Sciences
- Start
- Sep 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
01
Overview
Open-label trial of Lidocaine Hydrochloride Injection, without epinephrine and ketamine in chronic pain syndrome (CPS), sponsored by Hamilton Health Sciences. Primary endpoint: Pain Unpleasantness at 12 months. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrineketamine
03
Conditions
chronic pain syndrome (CPS)
Beyond the preview
Go deeper on NCT03249025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03249025.